Login / Signup
Cell-of-Origin Subtypes and Therapeutic Benefit from Polatuzumab Vedotin.
Adam C Palmer
David M Kurtz
Ash A Alizadeh
Published in:
The New England journal of medicine (2023)
Keyphrases
</>
single cell
cell therapy
hodgkin lymphoma